Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 12.20 · gapped above the open, never looked back. High/low 13.41 at 9:30 am ET, 12.20 at 3:45 pm ET.
Design Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“In February 2019, the Company entered into a Human Therapeutics Exclusive License Agreement (the "License Agreement") with the Wisconsin Alumni Research Foundation ("WARF").”
FILING10-K0001193125-26-098491cik 0001807120
“The underwriters for our initial public offering were Goldman Sachs & Co. LLC, SVB Leerink LLC, and Piper Sandler & Co.”
FILING10-K0001193125-26-098491cik 0001807120
“In February 2021, the Company entered into a lease agreement with Crossing Holdings, LLC to rent office space (the "Lease").”
FILING10-K0001193125-26-098491cik 0001807120
“In January 2019, the Company entered into an agreement with the Marlinspike Group, LLC ("Marlinspike Group") for research support, management, and business consulting services (the "2019 Consulting Agreement").”
FILING10-K0001193125-26-098491cik 0001807120
“The underwriters for our initial public offering were Goldman Sachs & Co. LLC, SVB Leerink LLC, and Piper Sandler & Co.”
FILING10-K0001193125-26-098491cik 0001807120
“The underwriters for our initial public offering were Goldman Sachs & Co. LLC, SVB Leerink LLC, and Piper Sandler & Co.”
FILING10-K0001193125-26-098491cik 0001807120
“In January 2026, the Lease was further amended via the Second Lease Amendment which was approved by the Audit Committee of the Board of Directors of the Company in accordance with the Company's Related Persons Transactions Policy, upon the sale of the leased premises to TREF V Hidden Valley Owner LLC.”
FILING10-K0001193125-26-098491cik 0001807120
Watchlist prices, news filtered to it, and its next report on your desk.
Design Therapeutics, Inc. has 7 disclosed suppliers and 0 disclosed customers. Each one is named in an SEC filing, either Design Therapeutics, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
No filing we have read names a customer of Design Therapeutics, Inc.. Customers appear here when Design Therapeutics, Inc. names them, or when a company names Design Therapeutics, Inc. as a supplier in its own annual report.
DSGN (Design Therapeutics, Inc.) has 7 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: PIPR −2.06%, in financials.